Related Experiment Video
Updated: Jan 9, 2026

14:23
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
Published on: April 16, 2012
24.7K
Progress and Future Perspectives of Treg Cell Therapy.
Kehua Fang1, Jinbao Zong2, Xiaotian Chang3,4
1Clinical Laboratory, The Affiliated Hospital of Qingdao University, 266000 Qingdao, Shandong, China.
Frontiers in Bioscience (Landmark Edition)
|December 6, 2025
Summary
Regulatory T cells (Tregs) show promise in cell therapy for managing immune responses and autoimmunity. This review summarizes Treg biology, preclinical data, and clinical trials, highlighting future therapeutic potential.
Area of Science:
- Immunology
- Cell Therapy
- Regulatory T cell biology
Background:
- Regulatory T cells (Tregs) are crucial for immune homeostasis, preventing autoimmunity and managing infections.
- Extensive research has advanced Treg biology and its therapeutic applications.
- Current Treg data primarily comes from animal models and in vitro studies.
Purpose of the Study:
- To provide an updated summary of Treg-targeting cell therapy.
- To review the unique characteristics of Tregs.
- To discuss the current state and future directions of Treg-based therapies.
Main Methods:
- Literature review of Treg biology.
- Analysis of animal experiments and clinical trials involving Treg injections.
- Discussion of limitations and future perspectives in Treg cell therapy.
Main Results:
- Tregs possess unique immunoregulatory functions.
- Preclinical and clinical studies demonstrate the potential of Treg injections.
- Challenges and limitations in current Treg applications were identified.
Conclusions:
- Treg-based cell therapy holds significant potential for various medical applications.
- Further research and clinical trials are needed to optimize Treg therapies.
- The safety and efficacy of Tregs may expand cell-based treatment options.
Related Concept Videos
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics
917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917
Cell-mediated Immune Responses
83.3K
Overview
83.3K

